SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

DEGUTI, M.M. et al. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Braz J Med Biol Res [online]. 2003, vol.36, n.6, pp. 739-745. ISSN 1414-431X.  http://dx.doi.org/10.1590/S0100-879X2003000600009.

    1. Ludwig J, Viggiano TR, McGill DB & Ott BJ (1980). Nonalcoholic steatohepatitis. Mayo Clinic Experiences with a hitherto unnamed disease. Mayo Clinic Proceedings, 55: 434-438.

    [ Links ]

    2. James OF & Day CP (1998). Nonalcoholic steatohepatitis (NASH): a disease of emerging identity and importance. Journal of Hepatology, 29: 495-501.

    [ Links ]

    3. Itoh S, Yougel T & Kawagoe K (1987). Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. American Journal of Gastroenterology, 82: 650-654.

    [ Links ]

    4. Diehl AM, Goodman Z & Ishak KG (1988). Alcohol-like disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology, 95: 1056-1062.

    [ Links ]

    5. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW & Powell LW (1990). The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology, 11: 74-80.

    [ Links ]

    6. Lee RG (1989). Nonalcoholic steatohepatitis: a study of 49 patients. Human Pathology, 20: 594-598.

    [ Links ]

    7. Bacon BR, Farakvash MJ, Janney CG & Neuschwander-Tetri BA (1994). Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology, 107: 1103-1109.

    [ Links ]

    8. Lonardo A, Bellini M, Tondelli E, Frazzoni M, Grisendi A, Pulvirenti M & Della-Casa G (1995). Nonoalcoholic steatohepatitis and the "bright liver syndrome": should a recently expanded clinical entity be further expanded? (Letter). American Journal of Gastroenterology, 90: 2072-2074.

    [ Links ]

    9. Propst A, Propst T, Judmaier G & Vogel W (1995). Prognosis in nonalcoholic steatohepatitis. Gastroenterology, 108: 1607.

    [ Links ]

    10. James O & Day C (1999). Nonalcoholic steatohepatitis: another disease of affluence. Lancet, 353: 1634-1636.

    [ Links ]

    11. Feder JN, Gnirke A, Thomas W et al. (1996). A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13: 399-408.

    [ Links ]

    12. Adams PC (1999). Population screening for hemochromatosis. Hepatology, 29: 1324-1327.

    [ Links ]

    13. Gochee PA, Powell LW, Cullen DJ, Sart DD, Rossi E & Olynyk JK (2002). A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology, 122: 646-651.

    [ Links ]

    14. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC & Powell LW (1998). Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology, 114: 311-318.

    [ Links ]

    15. Bonkovsky HL, Jawaid Q, Tortorelli K, Leclair P, Cobb J, Lambrecht RW & Banner BF (1999). Nonalcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in nonalcoholic steatohepatitis. Journal of Hepatology, 31: 421-429.

    [ Links ]

    16. Bonkovsky HL, Zivny J, Tortorelli K, Liu Q & Lambrecht RW (2000). Nonalcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload? (Letter). Journal of Hepatology, 33: 1025-1026.

    [ Links ]

    17. Datz C, Lalloz MRA, Vogel W et al. (1997). Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. Journal of Hepatology, 27: 773-779.

    [ Links ]

    18. Mendler M, Turlin B, Moirand R, Jouanolle A, Sapey T, Guyader D, Le Gall J, Brissot P, David V & Deugnier Y (1999). Insulin resistance-associated hepatic iron overload. Gastroenterology, 117: 1155-1163.

    [ Links ]

    19. Agostinho MF, Arruda VR, Basseres DS, Bordin S, Soares MCP, Menezes RC, Costa FF & Saad STO (1999). Mutation analysis of the HFE gene in Brazilian populations. Blood Cells, Molecules, and Diseases, 25: 324-327.

    [ Links ]

    20. Guillygomarc'h A, Mendler MH, Moirand R, Jouanolle AM, David V & Deugnier Y (2000). HFE mutations in insulin resistance-associated hepatic iron overload (Letter). Journal of Hepatology, 33: 515-516.

    [ Links ]

    21. Moirand R, Mendler MH, Guillygomarc'h A, Brissot P & Deugnier Y (2000). Nonalcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload? (Letter). Journal of Hepatology, 33: 1024-1026.

    [ Links ]

    22. Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'Neill RO & McCullough AJ (1999). Hepatic iron and nonalcoholic fatty liver disease. Hepatology, 30: 847-850.

    [ Links ]

    23. Alves-Silva J, da Silva-Santos M, Guimarães PE, Ferreira AC, Bandelt HJ, Pena SD & Prado VF (2000). The ancestry of Brazilian mtDNA lineages. American Journal of Human Genetics, 67: 444-461.

    [ Links ]

    24. Lumeng L & Crabb DW (1994). Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology, 107: 572-578.

    [ Links ]

    25. Franco LJ (1996). Diabetes in Japanese-Brazilians - influence of the acculturation process. Diabetes Research and Clinical Practice, 34 (Suppl): S51-S57.

    [ Links ]

    26. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M & Tanikawa K (1997). Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. Journal of Hepatology, 27: 103-107.

    [ Links ]

    27. Cotrim HP, Andrade ZA, Parana R, Portugal ML, Lyra LG & Freitas LAR (1999). Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers. Liver, 19: 299-304.

    [ Links ]

    28. Neuschwander-Tetri BA & Bacon BB (1996). Nonalcoholic steatohepatitis. Medical Clinics of North America, 80: 1147-1166.

    [ Links ]

    29. Vazquez CM, Molina MT & Ilundain A (1988). Distal small bowel resection increases mucosal permeability in the large intestine. Digestion, 40: 168-172.

    [ Links ]

    30. Schimpl G, Feierl G, Linni K, Uitz K, Ozbey H & Hollwarth ME (1999). Bacterial translocation in short-bowel syndrome in rats. European Journal of Pediatric Surgery, 9: 224-227.

    [ Links ]

    31. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH & Cummins AG (2001). The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of nonalcoholic steatohepatitis. Gut, 48: 206-211.

    [ Links ]